跳至主要内容
临床试验/CTRI/2019/08/020923
CTRI/2019/08/020923已完成未知

A STUDY TO EVALUATE THE ROLE OF DEXAMETHASONE IN PROPHYLAXIS OF POST OPERATIVE NAUSEA AND VOMITING IN LAPROSCOPIC CHOLECYSTECTOMY - Dexamethasone In PONV

ESI PGIMSR0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. ASA Class 1-2
  • 2. Patients undergoing elective laproscopic cholecystectomy

排除标准

  • 1. Patient refusal
  • 2. Patients who are pregnant or who have uncontrolled diabetes, glaucoma (all patients had blood glucose concentrations checked to exclude undiagnosed hyperglycaemia).
  • 3. Those with a known adverse reaction to dexamethasone or who were taking any systemic steroids (excluding steroid inhalers, suppositories, pessaries, eye drops, one-off local injections to a joint, or topical preparations) were excluded from the trial. 4. Patients previously taking regular oral or intravenous steroids had to have stopped taking these drugs at least three months before trial entry to be eligible.

研究者

发起方
ESI PGIMSR

相似试验